Dec 13, 2023 9:00am EST Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine
Nov 30, 2023 8:15am EST Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference
Nov 29, 2023 8:15am EST Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook
Nov 13, 2023 1:40pm EST Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson
Nov 09, 2023 8:15am EST Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
Nov 01, 2023 8:15am EDT Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
Sep 06, 2023 8:15am EDT Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 17, 2023 8:05am EDT Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care
Aug 10, 2023 4:15pm EDT Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference
